Siegfried breaks ground on new R&D center for drug substances in Switzerland
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The business and product range of Ipca and that of Unichem complements each others business and product range
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Apollo continues to invest in genomics technology and research for better patient care
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Subscribe To Our Newsletter & Stay Updated